SK
Satish Kumar Devarapu
About Satish Kumar Devarapu
Data last updated:
Satish Kumar Devarapu is a Director at Previpharma India Private Limited (since 2023). The company operates in Pharma. Previpharma India Private Limited reported revenue of ₹1.61 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Previpharma India Private Limited U46497TS2023PTC177885 | Director | 28 Dec 2023 | 2023 | ₹1.61 Cr (FY 2025) | Active |
Board colleagues of Satish Kumar Devarapu
| Name | DIN | Company | Designation |
|---|---|---|---|
| Gadda Sai Vijay Kumar | 10348989 | Previpharma India Private Limited | Director |
| Marc Mazur Michael | 10348988 | Previpharma India Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Satish Kumar Devarapu
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Satish Kumar Devarapu
Satish Kumar Devarapu currently holds 1 directorship: Previpharma India Private Limited (Director, since 28 Dec 2023, revenue ₹1.61 Cr (FY 2025)).
Satish Kumar Devarapu was first appointed on 28 Dec 2023 as Director at Previpharma India Private Limited.
The current boards of Satish Kumar Devarapu's companies include Gadda Sai Vijay Kumar (Previpharma India Private Limited), Marc Mazur Michael (Previpharma India Private Limited).